FPH.AX - Fisher & Paykel Healthcare Corporation Limited

ASX - ASX Delayed Price. Currency in AUD

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
http://www.fphcare.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees4,547

Key Executives

NameTitlePayExercisedYear Born
Mr. Lewis G. GradonMD, CEO & Exec. DirectorN/AN/A1961
Ms. Lyndal YorkChief Financial OfficerN/AN/AN/A
Dr. Andrew SomervellVP of Products & TechnologyN/AN/AN/A
Hayden BrownInvestor Relations Mang.N/AN/AN/A
Rachel ReynoldsSr. Communications Mang.N/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems. It provides its products for use in respiratory care, acute care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and within the hospital. The company offers adult respiratory products, including AIRVO 2 system, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, accessories, and interfaces; and homecare products that include masks, CPAP devices, data management products, humidifiers, and accessories. It has operations in North America, Europe, the Asia Pacific, and internationally. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Corporate Governance

Fisher & Paykel Healthcare Corporation Limited’s ISS Governance QualityScore as of June 25, 2019 is 6. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.